Benzyl 3-aminopyrrolidine-1-carboxylate;benzyl 3-(propan-2-ylamino)pyrrolidine-1-carboxylate;methane
C28H42N4O4 — CID 157491543
Data last refreshed: (MolForge compound catalog, from PubChem)
About Benzyl 3-aminopyrrolidine-1-carboxylate;benzyl 3-(propan-2-ylamino)pyrrolidine-1-carboxylate;methane
Benzyl 3-aminopyrrolidine-1-carboxylate;benzyl 3-(propan-2-ylamino)pyrrolidine-1-carboxylate;methane (PubChem CID 157491543) has the molecular formula C28H42N4O4 and a molecular weight of 498.67 g/mol. Its IUPAC name is benzyl 3-aminopyrrolidine-1-carboxylate;benzyl 3-(propan-2-ylamino)pyrrolidine-1-carboxylate;methane.
Molecular Properties
| Compound Name | Benzyl 3-aminopyrrolidine-1-carboxylate;benzyl 3-(propan-2-ylamino)pyrrolidine-1-carboxylate;methane |
|---|---|
| PubChem CID | 157491543 |
| Molecular Formula | C28H42N4O4 |
| Molecular Weight | 498.67 g/mol |
| Exact Mass | 498.32 |
| IUPAC Name | benzyl 3-aminopyrrolidine-1-carboxylate;benzyl 3-(propan-2-ylamino)pyrrolidine-1-carboxylate;methane |
| SMILES | C.CC(C)NC1CCN(C(=O)OCc2ccccc2)C1.NC1CCN(C(=O)OCc2ccccc2)C1 |
| InChI | InChI=1S/C15H22N2O2.C12H16N2O2.CH4/c1-12(2)16-14-8-9-17(10-14)15(18)19-11-13-6-4-3-5-7-13;13-11-6-7-14(8-11)12(15)16-9-10-4-2-1-3-5-10;/h3-7,12,14,16H,8-11H2,1-2H3;1-5,11H,6-9,13H2;1H4 |
| InChIKey | BXIIJJXALOEZOC-UHFFFAOYSA-N |
| XLogP | 4.39 |
| TPSA | 97.13 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 498.67 |
| LogP ≤ 5 | 4.39 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157491543 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.